ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹12 Cr | ₹15 Cr | ₹16 Cr | ₹12 Cr | ₹14 Cr |
What is the latest Total Non-Current Liabilities ratio of ALBERT DAVID ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹12 Cr |
| Mar2025 | ₹15 Cr |
| Mar2024 | ₹16 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹14 Cr |
How is Total Non-Current Liabilities of ALBERT DAVID Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹12 Cr | -17.53 | |
| Mar2025 | ₹15 Cr | -7.59 | |
| Mar2024 | ₹16 Cr | 34.17 | |
| Mar2023 | ₹12 Cr | -17.53 | |
| Mar2022 | ₹14 Cr | - | |
Compare Total Non-Current Liabilities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹505.3 Cr | 6.2% | 28.1% | 7.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹458,249.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,891.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹115,927.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,702.0 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | 6.2% |
28.1% |
7.6% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses